FingerprintDive into the research topics of 'Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy'. Together they form a unique fingerprint.
- Sort by:
Shuang Zhang, Yu Dong, Xiuping Chen, Chris Soon Heng Tan, Min Li, Kai Miao, Jia Hong Lu*
Research output: Contribution to journal › Article › peer-review